Validations: Hold-Time Studies (Bulk, Intermediate & Cleaning)

Bioburden Growth Kinetics: Modeling for Limits

Bioburden Growth Kinetics: Modeling for Limits Bioburden Growth Kinetics: Understanding Hold-Time Limits in the Pharmaceutical Industry The bioburden levels of pharmaceutical products are critical for ensuring product sterility and compliance with regulatory standards. Regulatory bodies such as the FDA, the EMA, and the MHRA impose stringent microbiological limits on pharmaceuticals. This step-by-step guide provides a comprehensive framework for understanding bioburden…

Continue Reading Bioburden Growth Kinetics: Modeling for Limits

Antimicrobial Preservatives: When They Help, When They Don’t

Antimicrobial Preservatives: When They Help, When They Don’t Antimicrobial Preservatives: When They Help, When They Don’t In the pharmaceutical industry, maintaining product integrity and safety during processing is paramount. This is particularly true regarding hold times for bulk and intermediate products, which can harbor potential microbial contamination. Antimicrobial preservatives are often utilized to mitigate these risks. However, the question remains—when…

Continue Reading Antimicrobial Preservatives: When They Help, When They Don’t

Common DHT/CHT Gaps—and How to Close Them

Common DHT/CHT Gaps—and How to Close Them Common DHT/CHT Gaps—and How to Close Them The pharmaceutical industry constantly strives to improve its validation processes, especially regarding cleaning and hold-time studies. This guide provides a comprehensive overview of dirty hold-time (DHT) and clean hold-time (CHT) considerations, particularly for bulk and intermediate materials. It offers actionable steps to close common gaps observed…

Continue Reading Common DHT/CHT Gaps—and How to Close Them

Bulk Hold-Time: Microbial Limits and Endotoxin Controls

Bulk Hold-Time: Microbial Limits and Endotoxin Controls Bulk Hold-Time: Microbial Limits and Endotoxin Controls The pharmaceutical industry must adhere to stringent regulatory requirements to ensure product quality and patient safety. One of the critical areas that require attention is the hold-time studies for bulks and intermediates, focusing on microbial limits and endotoxin control. This guide provides a step-by-step approach to…

Continue Reading Bulk Hold-Time: Microbial Limits and Endotoxin Controls

Intermediate Hold-Time: What to Trend and Why

Intermediate Hold-Time: What to Trend and Why The pharmaceutical industry is governed by stringent regulatory expectations that dictate the conditions under which products may be held during various processes. An essential aspect of maintaining product integrity is understanding and evaluating intermediate hold time. This article provides a detailed step-by-step guide on the critical aspects of intermediate hold time in pharmaceutical…

Continue Reading Intermediate Hold-Time: What to Trend and Why

Time/Temperature Mapping of Hold Tanks: Data That Matters

Time/Temperature Mapping of Hold Tanks: Data That Matters Time/Temperature Mapping of Hold Tanks: Data That Matters Introduction to Hold Time Studies Understanding hold time studies is critical for ensuring compliance with Good Manufacturing Practices (cGMP) in pharmaceutical manufacturing. These studies evaluate the stability, integrity, and sterility of products at various stages of manufacturing and are particularly relevant when discussing bioburden,…

Continue Reading Time/Temperature Mapping of Hold Tanks: Data That Matters

Vendor Skids and Vessels: Incoming Qualification of Hold Claims

Vendor Skids and Vessels: Incoming Qualification of Hold Claims The effective management of equipment hold time is crucial in pharmaceuticals, with implications on product quality and compliance to cGMP regulations. This article serves as a detailed step-by-step tutorial for healthcare professionals focusing on vendor skids and vessels, specifically concerning the incoming qualification of hold claims related to dirty and clean…

Continue Reading Vendor Skids and Vessels: Incoming Qualification of Hold Claims

Hold-Time in Single-Use Equipment: Special Considerations

Hold-Time in Single-Use Equipment: Special Considerations Hold-Time in Single-Use Equipment: Special Considerations The use of single-use equipment in pharmaceuticals presents unique challenges when assessing hold-time specifications. Understanding the critical aspects of cleaning processes, equipment hold time, and regulatory requirements is vital for ensuring compliance with FDA, EMA, and MHRA standards. This guide provides a step-by-step approach for professionals engaged in…

Continue Reading Hold-Time in Single-Use Equipment: Special Considerations

CHT in Aseptic Fill/Finish: Sterility Hooks and Records

CHT in Aseptic Fill/Finish: Sterility Hooks and Records Aseptic fill/finish operations are critical to ensuring the safety and efficacy of pharmaceutical products. One of the essential aspects of these operations is conducting Comprehensive Hold-Time Studies (CHT) for both dirty and clean equipment, as well as bulk hold time assessments. This article will provide a detailed guide for pharmaceutical professionals on…

Continue Reading CHT in Aseptic Fill/Finish: Sterility Hooks and Records

Sampling Plans for Complex Trains: Pipes, Tanks, and Filters

Sampling Plans for Complex Trains: Pipes, Tanks, and Filters Sampling Plans for Complex Trains: Pipes, Tanks, and Filters The pharmaceutical industry operates under strict regulatory guidelines set by organizations such as the US FDA, EMA, and MHRA. One crucial aspect of compliance involves managing equipment hold times, particularly for complex systems like pipes, tanks, and filters. This guide provides a…

Continue Reading Sampling Plans for Complex Trains: Pipes, Tanks, and Filters